… combination” (dacarbazine, carmustine, cisplatin, and tamoxifen) [13]. … phase II study
investigating the combination of tremelimumab and interferon alpha-2b , eight patients with stage …

… , stage two is also a localized form but with a high risk of … 2 which stimulates T cell proliferation
and Interferon alpha; the … of dacarbazine, carmustine, cisplatin, and tamoxifen and the …

… dacarbazine given alone or in combination with other chemotherapeutic agents or biological
modifiers such as cisplatin, vinblastine, vindesine, carmustine… as IL-2 or interferon-alpha 2B. …

… to dacarbazine alone were about half compared to combinations of cisplatin, vinblastine or
vindesine, and dacarbazine … ’ combining carmustine, cisplatin, and dacarbazine caused deep …

… , eg, cisplatin, vinblastine, and dacarbazine (CVD regiment) or cisplatin, dacarbazine,
carmustine, and tamoxifen (… The SIRT1 inhibitor EX-527 was tested in a phase II clinical study in …

… drugs like dacarbazine/carmustine/cisplatin/tamoxifen in … lomustine/dacarbazine (BOLD)
and interferon alpha-2b in 2003 … -1 inhibitor) [77] or phase II nivolumab-with/without ipilimumab …

… Dacarbazine has been the only chemotherapy agent to … patients, and demonstrated that
temozolomide and cisplatin … to the phase II stage of the ARTISTRY clinical trial series of in …

… , with a low response rate of 12.1–17.6% for dacarbazine [26,… In a phase II trial of temozolomide
(an oral alkylating agent) … drugs such as doxorubicin, cisplatin, and actinomycin-D, along …

… melanoma, including platinum-based drugs (cisplatin, carboplatin) and alkylating agents (dacarbazine, …
The majority of ongoing phase 2 and 3 clinical trials test the combination of …

… been tried include dacarbazine, temozolomide, cisplatin, benda… interferon alpha-2b for
metastatic uveal melanoma. Eur J … Group experience in phase II advanced melanoma clinical trials…